Neuropeptide substance P: A promising regulator of wound healing in diabetic foot ulcers

[Display omitted] In the past, neuropeptide substance P (SP) was predominantly recognized as a neuroinflammatory factor, while its potent healing activity was overlooked. This paper aims to review the regulatory characteristics of neuropeptide SP in both normal and diabetic wound healing. SP activel...

Full description

Saved in:
Bibliographic Details
Published in:Biochemical pharmacology 2023-09, Vol.215, p.115736-115736, Article 115736
Main Authors: Chen, Jitao, Ye, Penghui, Gu, Rifang, Zhu, Huan, He, Wenjie, Mu, Xingrui, Wu, Xingqian, Pang, Huiwen, Han, Felicity, Nie, Xuqiang
Format: Article
Language:English
Subjects:
Angiogenesis
Diabetic foot ulcers
Fibroblasts
Stem cell therapy
Substance P
Wound healing
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:[Display omitted] In the past, neuropeptide substance P (SP) was predominantly recognized as a neuroinflammatory factor, while its potent healing activity was overlooked. This paper aims to review the regulatory characteristics of neuropeptide SP in both normal and diabetic wound healing. SP actively in the regulation of wound healing-related cells directly and indirectly, exhibiting robust inflammatory properties, promoting cell proliferation and migration and restoring the activity and paracrine ability of skin cells under diabetic conditions. Furthermore, SP not only regulates healing-related cells but also orchestrates the immune environment, thereby presenting unique and promising application prospects in wound intervention. As new SP-based preparations are being explored, SP-related drugs are poised to become an effective therapeutic intervention for diabetic foot ulcers (DFU).
ISSN:0006-2952
1873-2968
DOI:10.1016/j.bcp.2023.115736